Indian pharmaceutical stocks opened lower on May 12 2026. The BSE Healthcare index declined 0.74% to 46,474.08 in the early morning trade. The broader market also remained weak with the Nifty 50 down 0.80% at 23,626.15 and the S&P BSE Sensex falling 0.87% to 75,355.76 as of around 9:43 AM.
Top Gainers in Pharma Sector
- Biocon was the notable gainer, rising 0.59% on BSE to ₹392.80 and 0.79% on NSE to ₹393.55.
- Strides Pharma Science posted a small gain of 0.15–0.18%.
- Lupin was nearly flat to marginally mixed.
- Sudeep Pharma Ltd. also traded close to flat.
Major Losers in Pharma Sector
- Orchid Pharma saw the steepest decline, falling 3.74% on BSE to ₹692.55 and 3.64% on NSE.
- J.B. Chemicals dropped 2.67% on BSE to ₹2,149 and 2.49% on NSE.
- Wockhardt declined 2.15–2.19%.
- Torrent Pharma fell 1.86–2.10%.
- Indoco Remedies was down 1.74–2.01%.
Other stocks trading lower included Mankind Pharma (-1.57–1.62%), Panacea Biotech , Zydus Lifesciences, IPCA Labs, Glenmark Pharma, Natco Pharma, Alembic Pharma, and Aarti Drugs.
Stocks such as Cipla, Sun Pharma, Aurobindo Pharma, Divis Laboratories, and Dr. Reddy’s Lab saw mild declines ranging from 0.2% to 0.8%.
Note: All prices and percentage changes are based on data as of 9:36 AM on BSE and 9:39 AM on NSE on May 12 2026. Market prices are volatile and keep changing. This is for informational purposes only and does not constitute investment advice. For the latest live prices, please check the official NSE and BSE websites.